Skip to content

Tobias Bracht

5 papers in the library · 6 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis

Journal of Psychopharmacology October 8, 2026 Gianluca A. Florineth, Anna L. Boeker, Tobias Bracht et al.

Background: Psilocybin-assisted therapy (PAT) has emerged as a promising intervention for alcohol use disorder (AUD), yet contemporary clinical evidence has not been systematically synthesized to validate its clinical utility and safety profile. Methods: Contemporary clinical trials of PAT for AUD were identified systematically from PubMed, PsycINFO, and Scopus by two independent reviewers....

Beyond the substance: A systematic review of psychological treatment frameworks in psychedelic-assisted therapy

Therapeutic Advances in Psychopharmacology October 8, 2026 Gianluca A. Florineth, Anna L. Boeker, Felix Müller et al.

Background Classic psychedelics show potential for treating psychiatric disorders, yet the psychological framework of psychedelic-assisted therapy (PAT) remains underspecified. As regulatory approval approaches, defining the contribution of psychological interventions to clinical outcomes is critical for both mechanism inference and implementation. Objectives To systematically review the...

Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.

JAMA Network Open January 2, 2026 Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker et al. 5 citations

Psychedelic-assisted therapy (PAT) is a novel intervention for depressive symptoms, typically delivered with additional psychological therapy sessions. Quantitative evidence on how this concomitant therapy contributes to treatment outcomes is limited, highlighting the need for a systematic synthesis. To evaluate whether the quantity of psychological therapy is associated with symptom reduction...

[Interventional psychiatric procedures and novel substances for the treatment of affective disorders: An overview and outlook].

Therapeutische Umschau April 1, 2025 Tobias Bracht, Daniela Hubl, Kristina Adorjan et al. 1 citation

Depression is one of the most common mental disorders. The effectiveness of pharmacological and psychotherapeutic treatments is well documented. Remission rates are around 67 % for pharmacological antidepressant initial and secondary treatment of a depressive episode in unipolar disorders. However, patients with a depressive episode who do not respond to at least two successive attempts at...

DOI: 10.23785/TU.2025.02.005 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Electroconvulsive therapy ect Ketamine/esketamine Depression therapy innovations +3

Associations of thalamocortical networks with reduced mindfulness in alcohol use disorder.

Frontiers in Psychiatry July 6, 2023 Niklaus Denier, Leila M. Soravia, Franz Moggi et al.

Background: Increased mindfulness is associated with reduced alcohol consumption in patients with alcohol use disorder (AUD) after residential treatment. However, the underlying neurobiological mechanism of mindfulness in AUD is unclear. Therefore, we investigate the structural and functional alterations of the thalamocortical system with a focus on the mediodorsal thalamic nucleus (MD-TN), the...